AVICANNA INC (AVCN.CA) Fundamental Analysis & Valuation

TSX:AVCN • CA05368K1003

Current stock price

0.15 CAD
0 (0%)
Last:

This AVCN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AVCN.CA Profitability Analysis

1.1 Basic Checks

  • AVCN had negative earnings in the past year.
  • AVCN had a negative operating cash flow in the past year.
  • In the past 5 years AVCN always reported negative net income.
  • In the past 5 years AVCN always reported negative operating cash flow.
AVCN.CA Yearly Net Income VS EBIT VS OCF VS FCFAVCN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • AVCN has a Return On Assets (-8.87%) which is comparable to the rest of the industry.
  • AVCN's Return On Equity of -60.37% is on the low side compared to the rest of the industry. AVCN is outperformed by 67.74% of its industry peers.
Industry RankSector Rank
ROA -8.87%
ROE -60.37%
ROIC N/A
ROA(3y)-47.14%
ROA(5y)-65.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVCN.CA Yearly ROA, ROE, ROICAVCN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K 4K 6K

1.3 Margins

  • With a decent Gross Margin value of 51.95%, AVCN is doing good in the industry, outperforming 70.97% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AVCN has grown nicely.
  • The Profit Margin and Operating Margin are not available for AVCN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.65%
GM growth 5Y8.17%
AVCN.CA Yearly Profit, Operating, Gross MarginsAVCN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. AVCN.CA Health Analysis

2.1 Basic Checks

  • AVCN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AVCN has more shares outstanding
  • Compared to 5 years ago, AVCN has more shares outstanding
  • Compared to 1 year ago, AVCN has an improved debt to assets ratio.
AVCN.CA Yearly Shares OutstandingAVCN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AVCN.CA Yearly Total Debt VS Total AssetsAVCN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • AVCN has an Altman-Z score of -4.78. This is a bad value and indicates that AVCN is not financially healthy and even has some risk of bankruptcy.
  • AVCN has a Altman-Z score of -4.78. This is in the lower half of the industry: AVCN underperforms 74.19% of its industry peers.
  • There is no outstanding debt for AVCN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.78
ROIC/WACCN/A
WACC8.57%
AVCN.CA Yearly LT Debt VS Equity VS FCFAVCN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • A Current Ratio of 0.90 indicates that AVCN may have some problems paying its short term obligations.
  • The Current ratio of AVCN (0.90) is worse than 90.32% of its industry peers.
  • A Quick Ratio of 0.38 indicates that AVCN may have some problems paying its short term obligations.
  • The Quick ratio of AVCN (0.38) is worse than 90.32% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.38
AVCN.CA Yearly Current Assets VS Current LiabilitesAVCN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. AVCN.CA Growth Analysis

3.1 Past

  • AVCN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.08%, which is quite impressive.
  • AVCN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.41%.
  • AVCN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 172.32% yearly.
EPS 1Y (TTM)77.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.13%
Revenue 1Y (TTM)2.41%
Revenue growth 3Y98.2%
Revenue growth 5Y172.32%
Sales Q2Q%1.96%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AVCN.CA Yearly Revenue VS EstimatesAVCN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
AVCN.CA Yearly EPS VS EstimatesAVCN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

0

4. AVCN.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AVCN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVCN.CA Price Earnings VS Forward Price EarningsAVCN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVCN.CA Per share dataAVCN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AVCN.CA Dividend Analysis

5.1 Amount

  • AVCN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AVCN.CA Fundamentals: All Metrics, Ratios and Statistics

AVICANNA INC

TSX:AVCN (4/22/2026, 7:00:00 PM)

0.15

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-31
Earnings (Next)05-12
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners14.49%
Ins Owner ChangeN/A
Market Cap18.85M
Revenue(TTM)25.50M
Net Income(TTM)-1.88M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.74
P/FCF N/A
P/OCF N/A
P/B 6.06
P/tB 7.78
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.2
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -8.87%
ROE -60.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.95%
FCFM N/A
ROA(3y)-47.14%
ROA(5y)-65.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.65%
GM growth 5Y8.17%
F-Score5
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 72.12%
Cap/Sales 2.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.38
Altman-Z -4.78
F-Score5
WACC8.57%
ROIC/WACCN/A
Cap/Depr(3y)42.25%
Cap/Depr(5y)69.89%
Cap/Sales(3y)2.21%
Cap/Sales(5y)24.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.41%
Revenue growth 3Y98.2%
Revenue growth 5Y172.32%
Sales Q2Q%1.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.69%
OCF growth 3YN/A
OCF growth 5YN/A

AVICANNA INC / AVCN.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AVICANNA INC (AVCN.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to AVCN.CA.


Can you provide the valuation status for AVICANNA INC?

ChartMill assigns a valuation rating of 0 / 10 to AVICANNA INC (AVCN.CA). This can be considered as Overvalued.


Can you provide the profitability details for AVICANNA INC?

AVICANNA INC (AVCN.CA) has a profitability rating of 1 / 10.